From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

As the nation's AIDS walk marks its 40th year in Los Angeles, organizers say medical advances have taken lowered visibility ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

The reasons to participate in the city’s annual AIDS Walk are as varied and diverse as the participants themselves. What is ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...

Op-ed: By investing in a peer workforce, policymakers can help Latinx communities overcome barriers to accessing quality HIV ...

Mpox’s present echoes HIV’s past—it’s a disease that has the potential to affect everyone and is more dangerous within a ...

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

Africa is contributing to groundbreaking data from the PURPOSE 2 study, which explores twice-yearly lenacapavir for HIV ...

About 1.9 million young women had HIV in 2023 due to gender inequality, poverty, and discrimination The dapivirine ring and dual prevention pill offer new protection options for women New tools ...

Be able to interpret effectively, accurately, and impartially, both receptively and expressively, using any necessary specialized vocabulary or terms without changes, omissions, or additions and while ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...